Brie McFarland, Ph.D., is a Senior Principal Consultant and Category Specialist for Expense Reduction Analysts. Over the past five years, her work with ERA has focused on cost containment projects which included analysis of medical/dental, pharmaceutical, and durable medical equipment (DME). In addition, she has worked on reference laboratory, surgical supplies, laboratory supplies, radiology supplies/nuclear medicine, and orthopedic supplies. Brie specializes in developing analytical methods to maximize high-volume savings for healthcare clients.
Prior to joining ERA, Brie held a variety of roles at Monsanto Company in St. Louis, Missouri. Her responsibilities included acting as a liaison between the computer scientists and the biological scientists in their IT department as well as people management roles in the deployment and support departments.
She received her Ph.D. from the University of Connecticut Health Center in Biomedical Sciences and Structural Biology. Her primary focus was developing a novel insecticide from funnel web spider venom. She holds numerous patents for her work. She received a B.S. in Genetic Engineering from Purdue University.